We used CRISPR/Cas9 system to knock out ROR1 in MDA-MD-231 cells, a basal-B breast cancer cell line [33] with known ROR1 expression [17] and selected two stable clones with confirmed loss of membrane expression by flow cytometry (Figure 2d). The gene discussed is ROR1; the disease is breast cancer.